Tillkännagivande • Jun 12
H.B. Fuller Company to Report Q2, 2026 Results on Jun 24, 2026 H.B. Fuller Company announced that they will report Q2, 2026 results After-Market on Jun 24, 2026 Tillkännagivande • May 26
Ancora Holdings Group Releases Letter to H.B. Fuller Company On May 26, 2026, Ancora Holdings Group, LLC announced that it had released a letter to H.B. Fuller Company which outlines the firm’s strong opposition to an acquisition of Advanced Medical Solutions Group plc (“AMS”) or any other business. Ancora stated that it contends the reckless pursuit of AMS Contradicts Management’s March 26 public commitment to avoid near-term deals in favor of necessary deleveraging and highlights the potential acquisition would increase leverage to above 4.0x net debt / proforma adjusted EBITDA and exacerbate the company’s depressed valuation multiple. Ancora added that it noted management lacks experience successfully integrating transformative acquisitions involving new product categories with regulatory complexities in foreign geographies and urged board to abandon its irresponsible pursuit of AMS and conduct a full review of strategic alternatives, including evaluating sale options following apparent buyer interest. Tillkännagivande • May 23
H.B. Fuller Company (NYSE:FUL) proposed to acquire Advanced Medical Solutions Group plc (AIM:AMS). H.B. Fuller Company (NYSE:FUL) proposed to acquire Advanced Medical Solutions Group plc (AIM:AMS) on April 30, 2026. A cash consideration will be paid by H.B. Fuller Company. As part of consideration, an undisclosed value is paid towards common equity of Advanced Medical Solutions Group plc.
The transaction is subject to consummation of due diligence investigation.
Ken Grahame, Soren Moller-Rasmussen, Terres Maloney, Cara Pazdon of Goldman Sachs & Co. LLC acted as financial advisor for H.B. Fuller Company. David Wyles, Charles Spencer, Christian Bradeen and Serdj Balach of Perella Weinberg Partners UK LLP acted as financial advisor for H.B. Fuller Company. Simon Elliott, Julian Oakley, Israel Akinrinsola and Harrison George of Evercore Partners International LLP acted as financial advisor for Advanced Medical Solutions Group plc. Gary Clarence, Harry Hargreaves and Nick Prowting of Investec Bank plc acted as financial advisor for Advanced Medical Solutions Group plc. Board Change • May 21
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 6 experienced directors. 2 highly experienced directors. Independent Director Celine Martin was the last director to join the board, commencing their role in 2025. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Tillkännagivande • Apr 17
H.B. Fuller Company Approves Regular Quarterly Cash Dividend, Payable on May 14, 2026 H.B. Fuller Company announced that its Board of Directors approved an increase in the Company’s regular quarterly cash dividend from $0.2350 per share of common stock to $0.2450 per share of common stock, payable on May 14, 2026 to shareholders of record at the close of business on April 30, 2026. Tillkännagivande • Mar 12
H.B. Fuller Company to Report Q1, 2026 Results on Mar 25, 2026 H.B. Fuller Company announced that they will report Q1, 2026 results After-Market on Mar 25, 2026 Tillkännagivande • Mar 05
H.B. Fuller Company, Annual General Meeting, Apr 16, 2026 H.B. Fuller Company, Annual General Meeting, Apr 16, 2026. Tillkännagivande • Jan 22
H.B. Fuller Company Announces Regular Quarterly Cash Dividend, Payable on February 19, 2026 H.B. Fuller Company announced that its Board of Directors declared a regular quarterly cash dividend of $0.2350 per share of common stock, payable on February 19, 2026 to shareholders of record at the close of business on February 5, 2026. Tillkännagivande • Jan 15
H.B. Fuller Company Provides Earnings Guidance for the First Quarter and Fiscal Year 2026 H.B. Fuller Company provides earnings guidance for the first quarter and fiscal year 2026. For the quarter, the company's Net revenue is expected to be down low single digits.
For the year, the company's Net revenue is expected to be flat to up 2%, with organic revenue expected to be approximately flat versus fiscal 2025. Tillkännagivande • Dec 31
H.B. Fuller Company to Report Q4, 2025 Results on Jan 14, 2026 H.B. Fuller Company announced that they will report Q4, 2025 results After-Market on Jan 14, 2026 Tillkännagivande • Oct 08
H.B. Fuller Company Announces Appointment of Celine Martin to Its Board of Directors, Effective December 1, 2025 H.B. Fuller Company announced the appointment of Celine Martin to its Board of Directors, effective December 1, 2025. Age:51, Ms. Martin brings more than 30 years of experience in the global MedTech industry, with deep expertise across surgical, cardiology, endovascular, and neurovascular segments. Her appointment reinforces H.B. Fuller’s strategic focus on expanding its presence in high-margin, high-growth markets like medical, and supports the company’s transformation journey toward achieving a greater than 20% EBITDA margin. Celine Martin, a seasoned medical device executive, joins H.B. Fuller’s Board of Directors effective December 1, 2025. Ms. Martin most recently served from 2022 to 2025 as the Company Group Chairman of the Cardiovascular & Specialty Solutions (CSS) Group at Johnson & Johnson, a global leader in the research and development, manufacture, and sale of a broad range of medical technologies. As a member of the Johnson & Johnson Medical Devices Group Operating committee, she led a diverse portfolio of medical device businesses including Electrophysiology, Neurovascular Intervention, Ear Nose and Throat and Breast Aesthetics. Before that, Ms. Martin held several roles of increasing responsibilities including Company Group Chairman, overseeing the surgical instrument portfolio of Ethicon, maker of Dermabond topical adhesives, from 2018 to 2021. Over her 30-year career, both in the U.S. and internationally, she played a vital role in advancing the ambition of Johnson & Johnson MedTech, including developing new categories and advancing standards of care for atrial fibrillation, stroke and minimally invasive surgery. Ms. Martin’s three-decade career at Johnson & Johnson included pivotal roles in advancing standards of care for atrial fibrillation, stroke, and minimally invasive surgery. Her global experience and cross-functional leadership in marketing, product development, and commercial strategy make her a strong addition to H.B. Fuller’s Board. Ms. Martin holds an MBA from Wake Forest University and a graduate degree in marketing from EM Normandie Business School. Tillkännagivande • Oct 03
H.B. Fuller Company Announces Regular Quarterly Cash Dividend, Payable on October 30, 2025 H.B. Fuller Company announced that its Board of Directors declared a regular quarterly cash dividend of $0.2350 per share of common stock, payable on October 30, 2025 to shareholders of record at the close of business on October 16, 2025. Tillkännagivande • Sep 25
H.B. Fuller Company Updates Earnings Guidance for the Fiscal 2025 H.B. Fuller Company updated earnings guidance for the fiscal 2025. For the period, Net revenue for fiscal 2025 is expected to be down 2% to 3%; organic revenue for fiscal 2025 is now expected to be flat to up 1%; the company now expect foreign exchange to adversely impact net revenue by approximately 1.0%. Tillkännagivande • Sep 11
H.B. Fuller Company to Report Q3, 2025 Results on Sep 24, 2025 H.B. Fuller Company announced that they will report Q3, 2025 results After-Market on Sep 24, 2025 Tillkännagivande • Jul 17
H.B. Fuller Company Declares Quarterly Cash Dividend, Payable on August 14, 2025 H.B. Fuller Company announced that its Board of Directors declared a regular quarterly cash dividend of $0.2350 per share of common stock, payable on August 14, 2025 to shareholders of record at the close of business on July 31, 2025. Tillkännagivande • Jun 26
H.B. Fuller Company Updates Earnings Guidance for Fiscal 2025 H.B. Fuller Company updated earnings guidance for fiscal 2025. As a result of its strong financial performance, the company is updating its previously communicated financial guidance for fiscal 2025. For the period, the company expects Net revenue for fiscal 2025 is now expected to be down 2% to 3%; organic revenue for fiscal 2025 is still expected to be flat to up 2%; company now expect foreign exchange to adversely impact net revenue by 1.0% to 1.5%. Tillkännagivande • Jun 12
H.B. Fuller Company to Report Q2, 2025 Results on Jun 25, 2025 H.B. Fuller Company announced that they will report Q2, 2025 results After-Market on Jun 25, 2025 Tillkännagivande • Apr 16
H.B. Fuller Increases Quarterly Dividend, Payable on May 13, 2025 H.B. Fuller company announced that its Board of Directors approved an increase in the Company’s regular quarterly cash dividend from $0.2225 per share of common stock to $0.2350 per share of common stock, payable on May 13, 2025 to shareholders of record at the close of business on April 29, 2025. Tillkännagivande • Mar 28
H.B. Fuller Launches Industry-Changing Commercial Roofing Adhesive with Canister Propellent Technology H.B. Fuller announced the launch of an innovative new technology that is driving change for commercial roofing installation and enhancing environmental responsibility. The H.B. Fuller Millennium PG-1 EF ECO2 is a high-performance roofing adhesive that eliminates the need for chemical blowing agents by using naturally occurring atmospheric gases. This powerful blend of gases called ECO2 Driven™? technology, operates without the use of high Global Warming Potential (GWP) propellants or Hydrofluoroolefins (HFOs), reducing the environmental impact of dispensing the adhesive without compromising adhesion strength. Designed to meet or exceed current North American environmental standards and align with emerging global regulations for Commercial Roofing, Millennium PG-1EF ECO2 is easy to use, while supporting sustainability goals. Canister-based adhesives can help reduce job site waste as canisters offer significant coverage area per unit and, when properly emptied, can be recycled depending on local regulations. As with the first-generation Millennium PG-1 EF ECO product, the "EF" stands for equipment-free. This two-part low-rise foam adhesive efficiently combines part A with part B dispensed through two canisters and features a unique spray nozzle that quickly and easily transitions between a ribbon or spatter spray. This enables the installation of insulation board and fleece-backed roofing membranes with one product that is easy to use and transport. In addition, compared to the mechanical fastening of roofing membranes, adhesives eliminate thermal bridging, achieve high wind uplift ratings, and minimize risks of leaks and building damage during re-roofing. These benefits support H.B. Fuller's commitment to both innovation and sustainability. With performance and patented ECO2 Driven™? Technology, Millennium PG-1 EF ECO 2 helps customers achieve their operational and sustainability goals while delivering value to roofing contractors and building owners. Tillkännagivande • Mar 27
H.B. Fuller Company Reaffirms Earnings Guidance for Fiscal Year 2025 H.B. Fuller Company reaffirmed earnings guidance for fiscal year 2025. For the year company expects, Net revenue growth to be down 2% to 4%, adjusting for the divestiture of the Flooring business, net revenue is expected to be up 1% to 2%; Organic revenue growth is expected to be flat to up 2% versus fiscal 2024. Tillkännagivande • Mar 13
H.B. Fuller Company to Report Q1, 2025 Results on Mar 26, 2025 H.B. Fuller Company announced that they will report Q1, 2025 results After-Market on Mar 26, 2025 Tillkännagivande • Mar 05
H.B. Fuller Company, Annual General Meeting, Apr 15, 2025 H.B. Fuller Company, Annual General Meeting, Apr 15, 2025. Tillkännagivande • Jan 23
H.B. Fuller Company Declares Regular Quarterly Cash Dividend, Payable on February 20, 2025 H.B. Fuller Company announced that its Board of Directors declared a regular quarterly cash dividend of $0.2225 per share of common stock, payable on February 20, 2025 to shareholders of record at the close of business on February 6, 2025. Tillkännagivande • Jan 16
H.B. Fuller Company Provides Consolidated Earnings Guidance for the Fiscal Year 2025 H.B. Fuller Company provided consolidated earnings guidance for the fiscal year 2025. Net revenue growth for fiscal 2025 is expected to be down 2% to 4%, adjusting for the divestiture of the Flooring business, net revenue is expected to be up 1% to 2%; Organic revenue growth is expected to be flat to up 2% versus fiscal 2024. Buy Or Sell Opportunity • Nov 09
Now 21% undervalued The stock has been flat over the last 90 days, currently trading at €72.50. The fair value is estimated to be €91.37, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue is forecast to grow by 8.3% in 2 years. Earnings are forecast to grow by 37% in the next 2 years. Tillkännagivande • Oct 21
H.B. Fuller Company Announces Chair of Board of Directors Changes H.B. Fuller Company announced that Teresa (Terry) J. Rasmussen has been appointed Chair of the company’s Board of Directors following the retirement of Lee R. Mitau, effective January 22, 2025. About Terry Rasmussen Rasmussen joined the H.B. Fuller Board of Directors in 2020 and currently serves as president and chief executive officer of Thrivent, a Fortune 500 diversified financial services organization. She brings world-class leadership and business acumen to the Board, along with significant expertise in organizational transformation. Before her current role, Rasmussen was president of Thrivent’s core life, health and annuities business after serving 10 years as senior vice president, general counsel and secretary. Prior to joining Thrivent, Rasmussen held a series of leadership roles at American Express, including serving as vice president and managing counsel. Earlier in her career, she was a trial attorney with the United States Department of Justice, Tax Division, as part of the Attorney General’s Honors Program. Rasmussen is a member of the Thrivent Board of Directors and the American Council of Life Insurers Board of Directors, where she is chair-elect. She is also on the board of the Walker Art Center, a world-renowned contemporary art museum in Minneapolis, Minnesota. She received her bachelor’s degree in accounting from Minnesota State University at Moorhead. After passing the CPA exam, she earned her Juris Doctor from the University of North Dakota. Tillkännagivande • Oct 07
H.B. Fuller Company Announces Retirement of Traci L. Jensen as Executive Vice President and Chief Administrative Officer, Effective November 30, 2024 On October 1, 2024, Traci L. Jensen, Executive Vice President and Chief Administrative Officer of H.B. Fuller Company, notified the Company of her retirement, effective November 30, 2024. Ms. Jensen has served as Executive Vice President and Chief Administrative Officer of the Company since December 2022 and previously served as Vice President, Global Business Process Improvement since December 2019 following a ten-year career at the Company. Ms. Jensen has played an important role on the Company’s executive team and has been instrumental in guiding the Company’s recent growth. Declared Dividend • Oct 07
Third quarter dividend of US$0.22 announced Shareholders will receive a dividend of US$0.22. Ex-date: 17th October 2024 Payment date: 31st October 2024 Dividend yield will be 1.2%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is well covered by both earnings (26% earnings payout ratio) and cash flows (19% cash payout ratio). The dividend has increased by an average of 8.3% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 27% over the next 2 years, which should provide support to the dividend and adequate earnings cover. Tillkännagivande • Oct 04
H.B. Fuller Company Declares Regular Quarterly Cash Dividend, Payable on October 31, 2024 H.B. Fuller Company announced that its Board of Directors declared a regular quarterly cash dividend of $0.2225 per share of common stock, payable on October 31, 2024 to shareholders of record at the close of business on October 17, 2024. Buy Or Sell Opportunity • Oct 01
Now 20% undervalued The stock has been flat over the last 90 days, currently trading at €71.50. The fair value is estimated to be €89.81, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue is forecast to grow by 8.3% in 2 years. Earnings are forecast to grow by 37% in the next 2 years. Tillkännagivande • Sep 26
H.B. Fuller Company Updates Earnings Guidance for the Year 2024 H.B. Fuller Company updated earnings guidance for the year 2024. For the year, the company updated net revenue growth is now expected to be up approximately 2% with organic revenue flat year-on-year. Reported Earnings • Sep 26
Third quarter 2024 earnings released: EPS: US$1.01 (vs US$0.69 in 3Q 2023) Third quarter 2024 results: EPS: US$1.01 (up from US$0.69 in 3Q 2023). Revenue: US$917.9m (up 1.9% from 3Q 2023). Net income: US$55.4m (up 47% from 3Q 2023). Profit margin: 6.0% (up from 4.2% in 3Q 2023). Revenue is forecast to grow 5.8% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings. Tillkännagivande • Sep 16
H.B. Fuller Company to Report Q3, 2024 Results on Sep 25, 2024 H.B. Fuller Company announced that they will report Q3, 2024 results After-Market on Sep 25, 2024 Tillkännagivande • Aug 07
H.B. Fuller Company (NYSE:FUL) acquired Hs Butyl Limited from a family. H.B. Fuller Company (NYSE:FUL) acquired Hs Butyl Limited from a family on August 6, 2024. Hs Butyl will operate within H.B. Fuller’s Construction Adhesives global business unit. Hs Butyl has reported annual sales of more than $23 million in 2023.
H.B. Fuller Company (NYSE:FUL) completed the acquisition of Hs Butyl Limited from a family on August 6, 2024. Declared Dividend • Jul 22
Second quarter dividend of US$0.22 announced Shareholders will receive a dividend of US$0.22. Ex-date: 31st July 2024 Payment date: 14th August 2024 Dividend yield will be 1.1%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is well covered by both earnings (28% earnings payout ratio) and cash flows (18% cash payout ratio). The dividend has increased by an average of 8.3% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 36% over the next 2 years, which should provide support to the dividend and adequate earnings cover. Tillkännagivande • Jul 17
H.B. Fuller Company Announces Quarterly Cash Dividend, Payable on August 14, 2024 H.B. Fuller Company announced that its Board of Directors declared a regular quarterly cash dividend of $0.2225 per share of common stock, payable on August 14, 2024 to shareholders of record at the close of business on July 31, 2024. H.B. Fuller has paid quarterly cash dividends on its common stock for 56 consecutive years. Reported Earnings • Jun 28
Second quarter 2024 earnings released: EPS: US$0.93 (vs US$0.74 in 2Q 2023) Second quarter 2024 results: EPS: US$0.93 (up from US$0.74 in 2Q 2023). Revenue: US$917.1m (up 2.1% from 2Q 2023). Net income: US$51.3m (up 27% from 2Q 2023). Profit margin: 5.6% (up from 4.5% in 2Q 2023). Revenue is forecast to grow 4.9% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings. Tillkännagivande • Jun 27
H.B. Fuller Company Updates Earnings Guidance for the Year 2024 H.B. Fuller Company updated earnings guidance for the year 2024. As a result of strong first half performance and recent acquisition activity, partially offset by the strengthening US Dollar, they are updating previously communicated financial guidance for fiscal 2024 as follows: Net revenue growth is now expected to be in the range of up 2% to 4% with organic revenue flat to up 2% year-on-year. Tillkännagivande • May 21
H.B. Fuller Company (NYSE:FUL) acquired ND Industries, Inc. from a family. H.B. Fuller Company (NYSE:FUL) acquired ND Industries, Inc. from a family on May 20, 2024.H.B. Fuller Company (NYSE:FUL) completed the acquisition of ND Industries, Inc. from a family on May 20, 2024. As part of the acquisition, products under ND Industries’ Vibra-Tite® brand will be added to H.B. Fuller’s existing epoxy, cyanoacrylate, UV curable and anaerobic product range. The new business, which includes five U.S. locations and 300 employees, will operate within H.B. Fuller's existing Engineering Adhesives global business unit. ND Industries, Inc. generated approximately $70 million in revenue in fiscal 2023. Recent Insider Transactions • May 01
Insider recently sold €326k worth of stock On the 29th of April, Zhiwei Cai sold around 5k shares on-market at roughly €70.13 per share. This transaction amounted to 13% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of €826k more than they bought in the last 12 months. Declared Dividend • Apr 15
First quarter dividend of US$0.22 announced Shareholders will receive a dividend of US$0.22. Ex-date: 24th April 2024 Payment date: 9th May 2024 Dividend yield will be 1.1%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is well covered by both earnings (29% earnings payout ratio) and cash flows (15% cash payout ratio). The dividend has increased by an average of 7.4% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 60% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Tillkännagivande • Apr 11
H.B. Fuller Company Regular Quarterly Cash Dividend, Payable on May 9, 2024 H.B. Fuller Company announced that its Board of Directors approved an increase in the Company’s regular quarterly cash dividend from $0.205 per share of common stock to $0.2225 per share of common stock, payable on May 9, 2024 to shareholders of record at the close of business on April 25, 2024. New Risk • Mar 30
New major risk - Financial position The company's interest payments are not well covered by earnings. Net interest cover: 2.7x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. This is currently the only risk that has been identified for the company. Reported Earnings • Mar 28
First quarter 2024 earnings released: EPS: US$0.57 (vs US$0.40 in 1Q 2023) First quarter 2024 results: EPS: US$0.57 (up from US$0.40 in 1Q 2023). Revenue: US$810.4m (flat on 1Q 2023). Net income: US$31.0m (up 42% from 1Q 2023). Profit margin: 3.8% (up from 2.7% in 1Q 2023). Revenue is forecast to grow 5.2% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings. Tillkännagivande • Mar 28
H.B. Fuller Company Reiterates Earnings Guidance for the Fiscal 2024 H.B. Fuller Company reiterated earnings guidance for the fiscal 2024. For the year 2024, Net revenue growth is expected to be in the range of up 2% to 6% with organic revenue flat to up 3% year-on-year. Tillkännagivande • Mar 14
H.B. Fuller Company to Report Q1, 2024 Results on Mar 27, 2024 H.B. Fuller Company announced that they will report Q1, 2024 results After-Market on Mar 27, 2024 Tillkännagivande • Feb 29
H.B. Fuller Company, Annual General Meeting, Apr 11, 2024 H.B. Fuller Company, Annual General Meeting, Apr 11, 2024, at 10:00 Central Standard Time. Agenda: To consider the election of three directors named in the attached Proxy Statement; to consider the ratification of the appointment of Ernst & Young LLP as H.B. Fuller’s independent registered public accounting firm for the fiscal year ending November 30, 2024; to consider non-binding advisory vote to approve the compensation of named executive officers as disclosed in the attached Proxy Statement; and to consider any other business that may properly be considered at the meeting or any adjournment thereof. Upcoming Dividend • Jan 30
Upcoming dividend of US$0.20 per share at 1.1% yield Eligible shareholders must have bought the stock before 06 February 2024. Payment date: 21 February 2024. Payout ratio is a comfortable 30% and this is well supported by cash flows. Trailing yield: 1.1%. Lower than top quartile of German dividend payers (5.1%). Lower than average of industry peers (6.0%). Declared Dividend • Jan 29
Fourth quarter dividend of US$0.20 announced Shareholders will receive a dividend of US$0.20. Ex-date: 6th February 2024 Payment date: 21st February 2024 Dividend yield will be 1.1%, which is lower than the industry average of 6.0%. Sustainability & Growth Dividend is well covered by both earnings (30% earnings payout ratio) and cash flows (17% cash payout ratio). The dividend has increased by an average of 7.4% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 22% over the next year, which should provide support to the dividend and adequate earnings cover. New Risk • Jan 26
New major risk - Financial position The company's interest payments are not well covered by earnings. Net interest cover: 2.9x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. This is currently the only risk that has been identified for the company. Tillkännagivande • Jan 25
H.B. Fuller Company Declares Regular Quarterly Cash Dividend, Payable on February 21, 2024 H.B. Fuller Company announced that its Board of Directors declared a regular quarterly cash dividend of $0.205 per share of common stock, payable on February 21, 2024 to shareholders of record at the close of business on February 7, 2024. Buy Or Sell Opportunity • Jan 23
Now 20% undervalued Over the last 90 days, the stock has risen 13% to €70.00. The fair value is estimated to be €87.67, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 8.4% over the last 3 years, while earnings per share has been flat. Revenue is forecast to grow by 3.4% in a year. Earnings are forecast to grow by 60% in the next year. Reported Earnings • Jan 18
Full year 2023 earnings released: EPS: US$2.67 (vs US$3.37 in FY 2022) Full year 2023 results: EPS: US$2.67 (down from US$3.37 in FY 2022). Revenue: US$3.51b (down 6.4% from FY 2022). Net income: US$144.9m (down 20% from FY 2022). Profit margin: 4.1% (down from 4.8% in FY 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 5.3% p.a. on average during the next 2 years, compared to a 2.9% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 18% per year, which means it is tracking significantly ahead of earnings growth. Tillkännagivande • Jan 18
H.B. Fuller Company Provides Financial Guidance for the Fiscal Year 2024 H.B. Fuller Company provided financial guidance for the fiscal year 2024. Net revenue growth for fiscal 2024 is expected to be in the range of up 2% to 6% with organic revenue flat to up 3% versus fiscal 2023, reflecting a rebound in demand following the unprecedented customer destocking activity in fiscal 2023, offset by slightly lower pricing as customers qualify lower price formulations and index-based pricing has a greater effect. Tillkännagivande • Oct 06
H.B. Fuller Company Declares Regular Quarterly Cash Dividend, Payable on November 2, 2023 H.B. Fuller Company announced that its Board of Directors declared a regular quarterly cash dividend of $0.205 per share of common stock, payable on November 2, 2023 to shareholders of record at the close of business on October 19, 2023. Tillkännagivande • Sep 28
H.B. Fuller Company Provides Earnings Guidance for the Fiscal Year 2023 H.B. Fuller Company provided earnings guidance for the fiscal year 2023. For the period, the company's net revenue is now expected to be in the range of $3.50 billion to $3.55 billion with organic revenue down 4.5% to 5.5% versus fiscal 2022, reflecting lower volume expectations due to customer destocking actions and slower than anticipated underlying demand conditions. Reported Earnings • Sep 28
Third quarter 2023 earnings released: EPS: US$0.69 (vs US$0.87 in 3Q 2022) Third quarter 2023 results: EPS: US$0.69 (down from US$0.87 in 3Q 2022). Revenue: US$900.6m (down 4.3% from 3Q 2022). Net income: US$37.6m (down 19% from 3Q 2022). Profit margin: 4.2% (down from 4.9% in 3Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 6.3% p.a. on average during the next 3 years, compared to a 2.1% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has increased by 17% per year, which means it is tracking significantly ahead of earnings growth. Upcoming Dividend • Jul 12
Upcoming dividend of US$0.20 per share at 1.2% yield Eligible shareholders must have bought the stock before 19 July 2023. Payment date: 03 August 2023. Payout ratio is a comfortable 27% and this is well supported by cash flows. Trailing yield: 1.2%. Lower than top quartile of German dividend payers (4.8%). Lower than average of industry peers (5.9%). Tillkännagivande • Jul 07
H.B. Fuller Company Declares Regular Quarterly Cash Dividend, Payable on August 3, 2023 H.B. Fuller Company announced that its Board of Directors declared a regular quarterly cash dividend of $0.205 per share of common stock, payable on August 3, 2023 to shareholders of record at the close of business on July 20, 2023. Reported Earnings • Jun 29
Second quarter 2023 earnings released: EPS: US$0.74 (vs US$0.88 in 2Q 2022) Second quarter 2023 results: EPS: US$0.74 (down from US$0.88 in 2Q 2022). Revenue: US$898.2m (down 9.6% from 2Q 2022). Net income: US$40.4m (down 14% from 2Q 2022). Profit margin: 4.5% (down from 4.8% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 5.5% p.a. on average during the next 3 years, compared to a 1.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 10% per year whereas the company’s share price has increased by 14% per year. Tillkännagivande • Jun 15
H.B. Fuller Company to Report Q2, 2023 Results on Jun 28, 2023 H.B. Fuller Company announced that they will report Q2, 2023 results at 4:00 PM, US Eastern Standard Time on Jun 28, 2023 Buying Opportunity • Jun 06
Now 22% undervalued after recent price drop Over the last 90 days, the stock is down 7.6%. The fair value is estimated to be €77.73, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 12%. Revenue is forecast to grow by 7.2% in 2 years. Earnings is forecast to grow by 70% in the next 2 years. Tillkännagivande • May 12
H.B. Fuller Company (NYSE:FUL) acquired Beardow & Adams (Adhesives) Limited. H.B. Fuller Company (NYSE:FUL) acquired Beardow & Adams (Adhesives) Limited on May 10, 2023. Beardow Adams generated approximately €130 million in revenue for the 2022 fiscal year. With a team of 200 employees globally, the Beardow Adams will operate within H.B. Fuller’s existing hygiene, health and consumable adhesives global business unit.
H.B. Fuller Company (NYSE:FUL) completed the acquisition of Beardow & Adams (Adhesives) Limited on May 10, 2023. Upcoming Dividend • Apr 12
Upcoming dividend of US$0.20 per share at 1.1% yield Eligible shareholders must have bought the stock before 19 April 2023. Payment date: 04 May 2023. Payout ratio is a comfortable 25% and this is well supported by cash flows. Trailing yield: 1.1%. Lower than top quartile of German dividend payers (4.7%). Lower than average of industry peers (5.5%). Reported Earnings • Mar 30
First quarter 2023 earnings released: EPS: US$0.40 (vs US$0.72 in 1Q 2022) First quarter 2023 results: EPS: US$0.40 (down from US$0.72 in 1Q 2022). Revenue: US$809.2m (down 5.5% from 1Q 2022). Net income: US$21.9m (down 43% from 1Q 2022). Profit margin: 2.7% (down from 4.5% in 1Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 4.2% p.a. on average during the next 3 years, compared to a 1.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 38% per year, which means it is tracking significantly ahead of earnings growth. Recent Insider Transactions • Feb 12
Insider recently sold €189k worth of stock On the 9th of February, Timothy Keenan sold around 3k shares on-market at roughly €66.78 per share. This transaction amounted to 13% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of €7.2m more than they bought in the last 12 months. Board Change • Feb 01
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Independent Director Chuck Lauber was the last director to join the board, commencing their role in 2023. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Tillkännagivande • Jan 25
H.B. Fuller Company Announces Quarterly Dividend, Payable on February 21, 2023 H.B. Fuller Company announced that its Board of Directors declared a regular quarterly cash dividend of $0.19 per share of common stock. The dividend is payable on February 21, 2023, to shareholders of record at the close of business on February 7, 2023. Reported Earnings • Jan 19
Full year 2022 earnings released: EPS: US$3.37 (vs US$3.05 in FY 2021) Full year 2022 results: EPS: US$3.37 (up from US$3.05 in FY 2021). Revenue: US$3.75b (up 14% from FY 2021). Net income: US$180.3m (up 12% from FY 2021). Profit margin: 4.8% (down from 4.9% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.1% p.a. on average during the next 2 years, compared to a 1.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 13% per year whereas the company’s share price has increased by 15% per year. Tillkännagivande • Jan 19
H.B. Fuller Company Provides Earnings Guidance for the Year 2023 H.B. Fuller Company provided earnings guidance for the year 2023. For the year, the revenue for 2023 is expected to be flat to down 3% versus 2022 and organic revenue growth for fiscal year 2023 is expected to be in the range of 2% to 4%, adjusting for the impact of the extra week in fiscal year 2022. Tillkännagivande • Jan 12
H.B. Fuller to Launch New Bio-Compatible Adhesive for Medical Applications H.B. Fuller announced the launch of Swift®melt 1515-I, its first bio-compatible product compliant in IMEA – India, Middle East, and Africa. The product is for medical tape applications to be used in stick-to-skin under unique climatic conditions, such as the high temperatures and humidity in the Indian sub-continent. Swift®melt 1515-I delivers effective high tack, secure and quick bonding, under high temperature and with shear resistance. The product, which shows excellent performance, balancing adhesion and ease of removal, was thoroughly tested and certified by ISO 10993-5 for cytotoxicity. Since it is not toxic to human cells, the adhesive can effectively be used in medical applications in hospitals and home care in stick-to-skin situations. The population pressure, the growing prevalence of diseases and the inherent increasing number of geriatric population, surgeries, chronic and traumatic wounds make the global medical tapes and bandages market one that is significantly rising. This segment is expected to reach USD 8.59 billion by 2026 globally, USD 850.1 million of which in India, as reported on the “Medical Tapes and Bandages Market – Global Forecast 2026” by MarketsandMarkets™. Tillkännagivande • Jan 06
H.B. Fuller Company to Report Q4, 2022 Results on Jan 18, 2023 H.B. Fuller Company announced that they will report Q4, 2022 results After-Market on Jan 18, 2023 Tillkännagivande • Nov 30
H.B. Fuller Company Elects Charles Lauber to Board of Directors, Effective January 23, 2023 H.B. Fuller Company announced that Charles (Chuck) T. Lauber was elected as an independent member to its board of directors, effective January 23, 2023. He has been appointed to serve on the audit committee and compensation committee of the board. Lauber was named executive vice president and chief financial officer of A. O. Smith Corporation in 2019. As chief financial officer, Lauber is responsible for all financial functions of the company, including treasury, controllership, cash management and investor relations. He also is actively involved in modernizing A. O. Smith’s operational capabilities and ESG (environmental, social and governance) strategy. Lauber has been integral to the company’s performance for over two decades, having served in financial leadership, operations strategy, and corporate development roles. A versatile executive, Chuck has driven the company’s growth through M&A and was vital to A. O. Smith’s successful expansion in the global water markets, including China and India. As CFO, he has led the charge to increase profit margins and enhance investor confidence, resulting in record earnings. Before joining A. O. Smith, Lauber held a number of auditing and management positions with Ernst & Young from 1984 to 1999. Lauber also serves as a board of director for the National Association of Manufacturers. He holds an MBA from the Kellogg School of Management at Northwestern University, and his BS in accounting from the University of Wisconsin at Whitewater. Recent Insider Transactions • Nov 16
President recently sold €4.7m worth of stock On the 11th of November, James Owens sold around 65k shares on-market at roughly €72.96 per share. This transaction amounted to 39% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. James has been a net seller over the last 12 months, reducing personal holdings by €6.1m. Recent Insider Transactions • Oct 20
President recently sold €1.4m worth of stock On the 18th of October, James Owens sold around 21k shares on-market at roughly €68.74 per share. This transaction amounted to 11% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was James' only on-market trade for the last 12 months. Upcoming Dividend • Oct 12
Upcoming dividend of US$0.19 per share Eligible shareholders must have bought the stock before 19 October 2022. Payment date: 03 November 2022. Payout ratio is a comfortable 21% but the company is not cash flow positive. Trailing yield: 1.2%. Lower than top quartile of German dividend payers (5.3%). Lower than average of industry peers (6.2%). Tillkännagivande • Oct 07
H.B. Fuller Announces Quarterly Dividend, Payable on November 3, 2022 H. B. Fuller Company announced that its Board of Directors declared a regular quarterly cash dividend of $0.19 per share of common stock. The dividend is payable on November 3, 2022, to shareholders of record at the close of business on October 20, 2022. Tillkännagivande • Sep 28
H.B. Fuller Company Announces Management Changes On September 26, 2022, H.B. Fuller Company announced a succession plan by which James J. Owens will retire from both the Board of Directors of the Company and the position of President and Chief Executive Officer of the Company, effective December 3, 2022. Mr. Owens will remain with the Company in a non-executive capacity through December 31, 2022 to assist with the CEO transition. The Company also announced that Celeste B. Mastin has been appointed President and Chief Executive Officer of the Company, effective December 4, 2022. Ms. Mastin has also been elected to the Board of Directors of the Company, effective December 4, 2022. Ms. Mastin, age 54, has served as Executive Vice President and Chief Operating Officer of the Company since March 7, 2022. Previously, Ms. Mastin served as CEO of PetroChoice Lubrication Solutions (2018-2022), one of the largest distributors of petroleum lubrication solutions in the United States. Prior to that, she held CEO roles at Distribution International Inc., (2013 to 2017), a leading fabricator and distributor of insulation and related supplies, and MMI Products Inc. (steel-based construction accessories), a Division of Oldcastle, and she served in executive leadership roles at Ferro Corporation (functional coatings and color solutions) and Bostik Adhesives (adhesives), now owned by Arkema. Mastin began her career at Shell Chemical Co. She currently serves on the board of directors of Granite Construction Inc. As President and Chief Executive Officer of the Company, Ms. Mastin will receive an annual base salary of $950,000. Also, she will be entitled to receive a target incentive opportunity of 120% of her base salary with a maximum incentive opportunity of up to 240% of her base salary under the Company’s short-term incentive plan. Ms. Mastin will also receive stock-based incentive awards under the Company’s long-term incentive plan consisting of non-qualified stock options, performance-based restricted stock units and time-based restricted stock units with a total annual value of 375% of her base salary, or $3,562,500. Ms. Mastin will enter into the Company’s standard form of CEO Severance Agreement and will continue to be covered by the Change-in-Control Agreement she entered into at the time of her appointment as Executive Vice President and Chief Operating Officer of the Company. As an executive director of the Company, Ms. Mastin will not receive any separate compensation for serving as a director of the Company. Tillkännagivande • Sep 27
H.B. Fuller Company Announces Changes to its Chief Executive Officer, Effective December 4, 2022 H.B. Fuller Company announced that Celeste Mastin, Executive Vice President and Chief Operating Officer, will succeed Jim Owens as H.B. Fuller’s Chief Executive Officer, effective December 4, 2022. Celeste Mastin currently serves as Executive Vice President and Chief Operating Officer of H.B. Fuller. She has more than 30 years’ experience in manufacturing and distribution with a successful track record of guiding companies’ growth through innovation, service improvement, global expansion, and acquisition. Prior to joining H.B. Fuller, Mastin served as CEO of PetroChoice Lubrication Solutions, one of the largest distributors of petroleum lubrication solutions in the United States. Prior to that, she held CEO roles at Distribution International Inc. and MMI Products Inc. (a division of Oldcastle), and she served in senior leadership roles at Ferro Corporation and Bostik Adhesives, now owned by Arkema. Mastin began her career at Shell Chemical Co. She currently serves on the board of directors of Granite Construction Inc. Mastin earned her MBA from the University of Houston and her BS in Chemical Engineering from Washington State University. Reported Earnings • Sep 23
Third quarter 2022 earnings released: EPS: US$0.87 (vs US$0.60 in 3Q 2021) Third quarter 2022 results: EPS: US$0.87 (up from US$0.60 in 3Q 2021). Revenue: US$941.2m (up 14% from 3Q 2021). Net income: US$46.5m (up 47% from 3Q 2021). Profit margin: 4.9% (up from 3.8% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 4.6% p.a. on average during the next 3 years, compared to a 1.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 11% per year whereas the company’s share price has increased by 13% per year. Tillkännagivande • Sep 23
H.B. Fuller Company (NYSE:FUL) acquired ZKLT Polymer Co., Ltd. for CNY 0.16 million. H.B. Fuller Company (NYSE:FUL) acquired ZKLT Polymer Co., Ltd. for CNY 0.16 million on August 16, 2022. H.B. Fuller acquired ZKLT Polymer for a base purchase price of CNY 102,812. We are also required to pay CNY 27,000, with half to be paid on each of the 12 month and 18-month anniversaries of the closing date, as well as contingent consideration up to CNY 30,000, following the completion of certain performance goals and conditions. The base purchase price was funded through existing cash. ZKLT will be included in our engineering adhesives operating segment.
H.B. Fuller Company (NYSE:FUL) completed the acquisition of ZKLT Polymer Co., Ltd. on August 16, 2022. Tillkännagivande • Sep 22
H.B. Fuller Company Revises Earnings Guidance for the Fiscal Year 2022 H.B. Fuller Company revised earnings guidance for the fiscal year 2022. Organic revenue growth for fiscal year 2022 is expected to be in the range of 17% to 18%, excluding the impact of the extra week. Tillkännagivande • Sep 16
H.B. Fuller Company Announces Director Changes, Effective September 15, 2022 On September 15, 2022, the Board of Directors of H.B. Fuller Company accepted the resignation of Dante C. Parrini as a director of the Company. In light of Mr. Parrini’s departure, the Board of Directors appointed Ruth S. Kimmelshue as the Chair of the Compensation Committee of the Board of Directors effective September 15, 2022. Tillkännagivande • Sep 08
H.B. Fuller Company to Report Q3, 2022 Results on Sep 21, 2022 H.B. Fuller Company announced that they will report Q3, 2022 results After-Market on Sep 21, 2022 
